CVS Health Corporation

CVS Health Corporation

World Rank (Jul-30-2023)
155
Market Cap (Jul-30-2023)
95.65 Billion USD
World Rank (Dec-25-2022)
99
Market Cap (Dec-25-2022)
122.94 Billion USD
World Rank (Jan-07-2022)
99
Market Cap (Jan-07-2022)
137.54 Billion USD
World Rank (Jan-01-2021)
154
Market Cap (Jan-01-2021)
89.40 Billion USD
Company Rank in Country in 2023
Rank in USA in July-2023 is 89
Company Rank in Country in 2022
Rank in USA in 2022 is 58
World Region
Americas
World Subregion
Northern America
CEO
Karen S. Lynch
Chairman
David W. Dorman
Founders
CVS Pharmacy
CVS Caremark
Employee Count
300,000
Employee Count as of Date
As on 2022
Headquarters Country
USA
Headquarters City/State
Rhode Island
Annual Revenue in USD
322,470 Million USD
Annual Operating Income in USD
16,082 Million USD
Annual Net Income in USD
4,149 Million USD
Annual Results for Period Ending
Dec-2022 ending year
Total Assets in USD
228,280 Million USD
Total Liabilities in USD
156,960 Million USD
Total Equity in USD
71,315 Million USD
Balance Sheet for Period Ending
Dec-2022 ending year
Business Sector LC
Healthcare
Pharmacy
Healthcare Service
Retail
HealthCare Products
Company Website
CVS Health Corporation - Healthcare - Retail Pharmacy
Wikipedia
Wikipedia
Yahoo
Yahoo @ NYSE
Company Profile

CVS Health Corporation is USA Based Healthcare Company and its services include Retail Pharmacy, Pharmacy Benefits Management, Clinical Services, Specialty Pharmacy, Digital Services. Headquarters is in USA.

CVS Health Corporation have three segments:

  • Health Care Benefits:

The Health Care Benefits segment offers a broad range of traditional, voluntary, and consumer-directed health insurance products and related services, including: 

medical, pharmacy, dental, and behavioral health plans 

medical management capabilities 

Medicare Advantage and Medicare Supplement plans n Prescription Drug Plans (PDP) 

Medicaid health care management services n health information technology products and services.

  • Pharmacy Services.

The Pharmacy Services segment provides a full range of pharmacy benefit management (PBM) solutions, including: 

plan design offerings and administration.

formulary management n retail pharmacy network management services.

mail order pharmacy.

specialty pharmacy and infusion services n clinical services n disease management services.

medical spend management.

  • Retail/Long-Term Care:

The Retail/LTC segment sells prescription drugs and a wide assortment of health and wellness products and general merchandise, and: 

provides health care services through its walk-in medical clinics.

provides medical diagnostic testing, administers vaccinations for illnesses such as influenza, COVID-19, and shingles.

conducts LTC operations, which distribute prescription drugs and provide other ancillary services to chronic care facilities and other care settings.

  • COVID-19 vaccines and 32+ million COVID-19 tests administered: 59 million.
  • Members with Aetna and Caremark: 100 million.
  • 9,000 retail locations with 1,200 walk-in clinics.
  • 4.5 million consumers visit CVS Health locations daily.
  • 2.4% overall drug trend and 5.8% specialty trend through as on 2021.
  • 4,000+ nurse practitioners and physician assistants currently employed.
  • 40 million unique digital customers.
  • 19 million virtual visits across CVS and Aetna in 2021, including 10 million behavioral health visits.

 


 

Facts About Company

As on 2022, CVS Health Corporation has 300,000 employees.

CVS Health Corporation annual revenue generated for period ending Dec-2022 was 322,467 million USD.

CVS Health Corporation annual net income generated for period ending Dec-2022 was 4,149 million USD.

As on 2021,  CVS Health Corporation has 29,5000 employees.

CVS Health Corporation annual revenue generated for period ending Dec-2021 was 46,385 million USD.

Split of Regional Revenue by business segment  for period ending Dec-2021:

  • Products: 203,738 million USD.
  • Premiums: 76,132 million USD.
  • Services: 11,042 million USD.
  • Net investment income: 1,199 million USD.

CVS Health Corporation  annual net income generated for period ending Dec-2021 was 7,910 million USD.

Annual Results Summary LC

CVS HEALTH CORPORATION - Annual Results - Revenue and Net Profit - in Million USD:

Year - EndingRevenueOperating IncomeNet Income
Dec-2022322,46716,0824,149
Dec-2021292,11114,9827,910
Dec-2020268,70613,9117,179
Dec-2019156,77611,9876,634
Dec-2018194,57910,170-594  (Loss)
Dec-2017184,7659,5176,622
Balance Sheet Summary LC

CVS HEALTH CORPORATION - Balance Sheet Summary - in Million USD:

Year Ending:Total AssetsTotal LiabilitiesTotal Equity
Dec-2022228,275156,96071,315
Dec-2021232,999157,61875,381
Dec-2020230,715161,32669,389
Dec-2019222,449158,58563,864
Dec-2018196,456138,23158,225
Dec-201795,13157,44037,691
Dec-201694,46257,63236,830
Quarterly Results Summary LC

CVS HEALTH CORPORATION - Quarterly Results - Revenue and Net Profit - in Million USD:

Quarterly EndingTotal RevenueGross ProfitOperating IncomeNet Income
Sep-202389,76413,5773,7012,261
Jun-202388,92113,6033,7301,901
Mar-202385,278 13,3753,7952,136
Dec-202283,84613,8133,7292,302
Sep-202281,15913,3753,769-3,416
Jun-202280,63613,7404,5692,951
Mar-202276,82613,3663,4902,312
Dec-202176,60413,6523,5871,306
Sep-202173,79412,7023,4921,598
Jun-202172,61613,1954,3262,783
Mar-202169,09712,4993,5772,223
Dec-202069,55411,9572,524973
Sep-202067,05611,7203,2491,224
Jun-202065,34113,3484,6802,975
Mar-202066,75512,0213,4582,007
Dec-201966,88911,6913,0371,747
Founded Year
1996
Institutional Investors

Top 30 Institutional Holder Names in CVS HEALTH CORPORATION as on SEP-30-2023

RANKINSTITUTION NAMEDATESHARES HELDCHANGE (SHARES)CHANGE (%)VALUE (IN 1,000S)
1VANGUARD GROUP INC09/30/202311,71,62,6264,85,7440.42%$8,099,452
2BLACKROCK INC.09/30/20238,67,33,963-70,00,887-7.47%$5,995,919
3STATE STREET CORP09/30/20235,40,99,124-17,78,263-3.18%$3,739,872
4CAPITAL WORLD INVESTORS09/30/20234,04,25,07199,34,26932.58%$2,794,585
5MORGAN STANLEY09/30/20233,11,14,704-21,38,720-6.43%$2,150,959
6FMR LLC09/30/20232,74,87,23861,94,44129.09%$1,900,193
7DODGE & COX09/30/20232,67,22,9821,06,98,56066.76%$1,847,360
8GEODE CAPITAL MANAGEMENT, LLC09/30/20232,39,30,1306,04,8432.59%$1,654,290
9CAPITAL INTERNATIONAL INVESTORS09/30/20232,28,53,8972,00,33,737710.38%$1,579,890
10BANK OF AMERICA CORP /DE/09/30/20231,64,10,362-1,40,757-0.85%$1,134,448
11INVESCO LTD.09/30/20231,60,95,890-9,06,597-5.33%$1,112,709
12NORGES BANK12/31/20221,52,95,8088,59,8055.96%$1,057,399
13JPMORGAN CHASE & CO09/30/20231,44,03,752-5,56,680-3.72%$995,731
14NORTHERN TRUST CORP09/30/20231,42,14,2963,05,5642.20%$982,634
15ROYAL BANK OF CANADA09/30/20231,41,36,9203,05,1122.21%$977,285
16CAPITAL RESEARCH GLOBAL INVESTORS09/30/20231,34,32,64977,95,109138.27%$928,599
17CHARLES SCHWAB INVESTMENT MANAGEMENT INC09/30/20231,27,17,8253,24,3912.62%$879,183
18GOLDMAN SACHS GROUP INC09/30/20231,15,42,907-6,86,159-5.61%$797,961
19PRICE T ROWE ASSOCIATES INC /MD/09/30/20231,07,07,0379,42,7959.66%$740,177
20BANK OF NEW YORK MELLON CORP09/30/20231,06,78,0782,66,6502.56%$738,176
21FRANKLIN RESOURCES INC09/30/20231,04,19,011-6,26,293-5.67%$720,266
22LEGAL & GENERAL GROUP PLC09/30/202396,01,953-2,93,403-2.97%$663,783
23NORDEA INVESTMENT MANAGEMENT AB09/30/202395,43,017-2,98,811-3.04%$659,709
24DIMENSIONAL FUND ADVISORS LP09/30/202395,32,084-1,75,420-1.81%$658,953
25UBS GROUP AG09/30/202376,94,134-8,42,844-9.87%$531,895
26HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC09/30/202368,49,0865,15,3258.14%$473,477
27MACQUARIE GROUP LTD09/30/202363,30,317-1,90,378-2.92%$437,615
28UBS ASSET MANAGEMENT AMERICAS INC09/30/202363,21,510-3,14,000-4.73%$437,006
29AMERIPRISE FINANCIAL INC09/30/202363,03,199-24,74,949-28.19%$435,740
30BARCLAYS PLC09/30/202359,03,8704,20,7167.67%$408,135
Stock Category LC
S&P 500
Stock Exchange LC
NYSE